These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11684795

  • 1. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome.
    Matsukura H, Inaba S, Shinozaki K, Yanagihara T, Hara M, Higuchi A, Takada T, Tanizawa T, Miyawaki T.
    Am J Nephrol; 2001; 21(5):362-7. PubMed ID: 11684795
    [Abstract] [Full Text] [Related]

  • 2. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA, Esezobor CI, Lesi FE.
    Pan Afr Med J; 2016 Apr; 25():258. PubMed ID: 28293374
    [Abstract] [Full Text] [Related]

  • 4. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT, Yang LY.
    J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 6. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [Abstract] [Full Text] [Related]

  • 7. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
    Hari P, Bagga A, Jindal N, Srivastava RN.
    Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
    [Abstract] [Full Text] [Related]

  • 8. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.
    Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ.
    Am J Kidney Dis; 1987 Feb; 9(2):108-14. PubMed ID: 3826059
    [Abstract] [Full Text] [Related]

  • 9. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
    Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
    [Abstract] [Full Text] [Related]

  • 11. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H, Jaureguiberry G, Dufek S, Tullus K, Bockenhauer D.
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [Abstract] [Full Text] [Related]

  • 12. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 13. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M, Adarmouch L, Amine M, Bourrahouat A, Ait Sab I, Sbihi M.
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [Abstract] [Full Text] [Related]

  • 14. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [Abstract] [Full Text] [Related]

  • 15. Treatment aspects of primary nephrotic syndrome in adults.
    Rasić S, Uncanin S, Dzemidzić J, Aganović K, Srna A, Rasić I.
    Bosn J Basic Med Sci; 2006 May; 6(2):16-20. PubMed ID: 16879107
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 17. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA, Levtchenko EN, Wetzels JF.
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM, Bercowsky A, Osofsky SG, Soothill JF.
    Lancet; 1975 Jan 11; 1(7898):55-8. PubMed ID: 46019
    [Abstract] [Full Text] [Related]

  • 20. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.
    Am J Kidney Dis; 2017 May 11; 69(5):637-646. PubMed ID: 28089478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.